Jul 23, 2025 12:00
JUNS - Jupiter Neurosciences, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.55 -0.07 (-4.52%) | --- | --- | --- | 0.01 (0.65%) | 0.0 (0.0%) | -0.01 (-0.67%) | -0.01 (-0.67%) |
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.07
- Diluted EPS:
- -0.07
- Basic P/E:
- -21.1429
- Diluted P/E:
- -21.1429
- RSI(14) 1m:
- 0.0
- VWAP:
- 1.48
- RVol:
- 0.3117
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price decrease 1m | 1.52 -0.03 (-1.94%) | Oct 15 15:48 |
| 1m | Price increase 1m | 1.55 +0.02 (+1.33%) | Oct 15 15:10 |
| 1m | Price increase 1m | 1.5 +0.01 (+1.01%) | Oct 15 11:32 |
| 10m | Price increase 10m | 1.58 +0.06 (+3.9%) | Oct 15 09:51 |
| 10m | Price increase 10m | 1.59 +0.06 (+3.91%) | Oct 15 09:33 |
Related News
Jun 23, 2025 12:00
Dec 04, 2024 21:56